18F-氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描在结外自然杀伤/ T细胞淋巴瘤中的应用：一种综合评估方法
F-FDG PET/CT in extranodal natural killer/T-cell lymphoma: a comprehensive evaluation method.
作者信息
Zhang Xiaoyue, Huang Wenpeng, Qiu Yongkang, Chen Zhao, Song Lele, Yang Qi, Kang Lei
机构信息
Department of Nuclear Medicine, Peking University First Hospital Beijing 100034, PR China.
出版信息
Am J Nucl Med Mol Imaging. 2023 Dec 25;13(6):245-258. eCollection 2023.
Abstract
Extranodal NK/T-cell lymphoma (ENKTL) is an uncommon subtype of non-Hodgkin's lymphoma that is closely related to Epstein-Barr virus (EBV) infection. ENKTL exhibits distinctive clinicopathological features among lymphomas and has poor overall survival in the absence of effective treatment. The timely and accurate diagnosis of ENKTL is crucial for effective treatment and a positive prognosis. F-Fluorodeoxyglucose-positron emission tomography/computed tomography (F-FDG PET/CT) has emerged as an invaluable diagnostic modality for staging, curative effect evaluation, and prognosis analysis in ENKTL. We herein provide a comprehensive overview of the advances in the application of F-FDG PET/CT in patients with ENKTL.
摘要
结外NK/T细胞淋巴瘤（ENKTL）是一种罕见的非霍奇金淋巴瘤亚型，与爱泼斯坦-巴尔病毒（EBV）感染密切相关。ENKTL在淋巴瘤中表现出独特的临床病理特征，在缺乏有效治疗的情况下总体生存率较低。ENKTL的及时准确诊断对于有效治疗和良好预后至关重要。F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描（F-FDG PET/CT）已成为ENKTL分期、疗效评估和预后分析的重要诊断手段。我们在此全面概述F-FDG PET/CT在ENKTL患者中的应用进展。
相似文献
1
F-FDG PET/CT in extranodal natural killer/T-cell lymphoma: a comprehensive evaluation method.
Am J Nucl Med Mol Imaging. 2023 Dec 25;13(6):245-258. eCollection 2023.
2
[Prognostic value of bone marrow (18)F-FDG uptake pattern of pretreatment PET-CT in extranodal NK/T cell lymphoma].
Zhonghua Zhong Liu Za Zhi. 2020 Oct 23;42(10):885-890. doi: 10.3760/cma.j.cn112152-20191115-00739.
3
Positron emission tomography/computed tomography in the diagnosis, staging, and prognostic evaluation of natural killer/T-cell lymphoma.
J Int Med Res. 2018 Dec;46(12):4920-4929. doi: 10.1177/0300060518804375. Epub 2018 Oct 17.
4
Dynamic evaluation of the prognostic value of F-FDG PET/CT in extranodal NK/T-cell lymphoma, nasal type.
Ann Hematol. 2021 Apr;100(4):1039-1047. doi: 10.1007/s00277-021-04466-3. Epub 2021 Feb 26.
5
[Prognostic value of pretreatment (18)F-FDG PET-CT metabolic parameters in patients with advanced extranodal NK/T cell lymphoma].
Zhonghua Zhong Liu Za Zhi. 2019 Nov 23;41(11):831-836. doi: 10.3760/cma.j.issn.0253-3766.2019.11.006.
6
Assessment of the prognostic capacity of pretreatment, interim, and post-therapy (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma, nasal type.
Ann Nucl Med. 2015 Jun;29(5):442-51. doi: 10.1007/s12149-015-0964-8. Epub 2015 Mar 24.
7
F-FDG PET/CT Plays a Limited Role in Replacing Bone Marrow Biopsy for Newly Diagnosed Advanced-Stage Patients With Extranodal Natural Killer/T-Cell Lymphoma.
Front Oncol. 2022 Jul 26;12:894804. doi: 10.3389/fonc.2022.894804. eCollection 2022.
8
Appropriate timing to perform an interim F-FDG PET/CT in patients with nasal-type extranodal natural killer/T cell lymphoma.
Ann Hematol. 2024 Mar;103(3):885-892. doi: 10.1007/s00277-023-05562-2. Epub 2023 Nov 30.
9
Weakly supervised deep learning for determining the prognostic value of F-FDG PET/CT in extranodal natural killer/T cell lymphoma, nasal type.
Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3151-3161. doi: 10.1007/s00259-021-05232-3. Epub 2021 Feb 20.
10
Development and validation of an F-FDG PET radiomic model for prognosis prediction in patients with nasal-type extranodal natural killer/T cell lymphoma.
Eur Radiol. 2020 Oct;30(10):5578-5587. doi: 10.1007/s00330-020-06943-1. Epub 2020 May 20.
引用本文的文献
1
Metabolic parameter of baseline 18 F-FDG PET/CT with PINK models improve the prediction of treatment outcome in extranodal NK/T-cell lymphoma treated with P-GEMOX chemotherapy.
Ann Hematol. 2025 Feb;104(2):1069-1078. doi: 10.1007/s00277-025-06243-y. Epub 2025 Feb 11.
2
Primary perianal alveolar rhabdomyosarcoma with uncommon metastatic sites: a case report and follow-up using F-FDG PET/CT.
Front Med (Lausanne). 2024 Dec 17;11:1474698. doi: 10.3389/fmed.2024.1474698. eCollection 2024.
3
Recent advances in imaging and artificial intelligence (AI) for quantitative assessment of multiple myeloma.
Am J Nucl Med Mol Imaging. 2024 Aug 25;14(4):208-229. doi: 10.62347/NLLV9295. eCollection 2024.
本文引用的文献
1
F-FDG PET/CT Plays a Limited Role in Replacing Bone Marrow Biopsy for Newly Diagnosed Advanced-Stage Patients With Extranodal Natural Killer/T-Cell Lymphoma.
Front Oncol. 2022 Jul 26;12:894804. doi: 10.3389/fonc.2022.894804. eCollection 2022.
2
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.
Leukemia. 2022 Jul;36(7):1720-1748. doi: 10.1038/s41375-022-01620-2. Epub 2022 Jun 22.
3
Nasal-Type NK/T-Cell Lymphoma Involvement of the Vocal Cord on FDG PET/CT.
Clin Nucl Med. 2022 Oct 1;47(10):914-915. doi: 10.1097/RLU.0000000000004276. Epub 2022 May 27.
4
Extranodal NK/T-Cell Lymphoma With Widespread Cutaneous and Subcutaneous Involvement on 18 F-FDG PET/CT.
Clin Nucl Med. 2022 Oct 1;47(10):e630-e631. doi: 10.1097/RLU.0000000000004205. Epub 2022 Apr 27.
5
FDG PET/CT Showing a Primary Vaginal NK/T Cell Lymphoma.
Clin Nucl Med. 2022 Mar 1;47(3):273-274. doi: 10.1097/RLU.0000000000003906.
6
Assessment of the prognostic value of interim fluorodeoxyglucose positron emission tomography/computed tomography in nasal-type extranodal natural killer/T-cell lymphoma.
Quant Imaging Med Surg. 2021 Apr;11(4):1220-1233. doi: 10.21037/qims-20-620.
7
End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA.
Blood Adv. 2021 Mar 9;5(5):1283-1290. doi: 10.1182/bloodadvances.2020002690.
8
Dynamic evaluation of the prognostic value of F-FDG PET/CT in extranodal NK/T-cell lymphoma, nasal type.
Ann Hematol. 2021 Apr;100(4):1039-1047. doi: 10.1007/s00277-021-04466-3. Epub 2021 Feb 26.
9
Weakly supervised deep learning for determining the prognostic value of F-FDG PET/CT in extranodal natural killer/T cell lymphoma, nasal type.
Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3151-3161. doi: 10.1007/s00259-021-05232-3. Epub 2021 Feb 20.
10
Nomograms based on SUVmax of F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma.
Cancer Imaging. 2021 Jan 8;21(1):9. doi: 10.1186/s40644-020-00379-y.
Zotero 插件